{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:00:20Z","timestamp":1781614820104,"version":"3.54.5"},"reference-count":154,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>\n                    Glioblastoma (GBM), the most aggressive primary brain tumor, remains highly resistant to conventional therapies because of its pronounced intratumoral heterogeneity, adaptive plasticity, and complex tumor microenvironment. Increasing evidence indicates that extracellular vesicles (EVs) play central roles in mediating intercellular communication within GBM and contribute to multiple mechanisms associated with therapeutic resistance. This review critically examines the biogenesis, molecular cargo composition, and functional heterogeneity of GBM-derived EVs, with particular emphasis on their involvement in chemoresistance-related processes, including apoptosis evasion, DNA repair modulation, stemness maintenance, immune reprogramming, metabolic adaptation, and remodeling of the tumor microenvironment. EV-associated cargos, including microRNAs, long non-coding RNAs, circular RNAs, proteins, and lipids, appear to coordinately regulate interconnected resistance networks under therapeutic pressure rather than functioning through isolated pathways. Importantly, this review distinguishes between findings derived from\n                    <jats:italic>in vitro<\/jats:italic>\n                    systems, preclinical\n                    <jats:italic>in vivo<\/jats:italic>\n                    models, and patient-derived clinical evidence in order to better contextualize the current translational relevance of EV-based mechanisms. Emerging evidence further suggests that EV-mediated effects may be context-dependent and, in certain settings, may exert non-canonical or antiproliferative functions. In addition to their pathological roles, EVs are increasingly being investigated as potential biomarkers and therapeutic platforms for GBM management. However, substantial translational barriers remain, including EV heterogeneity, lack of isolation standardization, scalability limitations, cargo-loading inefficiency, regulatory challenges, and incomplete understanding of off-target and physiological effects. By integrating mechanistic insights with translational considerations, this review provides a balanced framework for understanding the dual and context-dependent roles of EVs in GBM progression and therapeutic resistance while highlighting critical knowledge gaps that must be addressed before clinical implementation.\n                  <\/jats:p>","DOI":"10.3389\/fnmol.2026.1705115","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:38:39Z","timestamp":1781588319000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracellular vesicles as nanocarriers in glioblastoma: implications for chemoresistance and immune evasion"],"prefix":"10.3389","volume":"19","author":[{"given":"Faezeh","family":"Ebrahimi","sequence":"first","affiliation":[{"name":"Student Research Committee, Rafsanjan University of Medical Sciences","place":["Rafsanjan, Iran"]},{"name":"USERN Office, Rafsanjan University of Medical Sciences","place":["Rafsanjan, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha Rahavi","family":"Ezabadi","sequence":"additional","affiliation":[{"name":"Student Research Committee, Shahid Sadoughi University of Medical Sciences","place":["Yazd, Iran"]},{"name":"School of Medicine, Shahid Sadoughi University of Medical Sciences","place":["Yazd, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hale","family":"Asghari","sequence":"additional","affiliation":[{"name":"Student Research Committee, Department of Medicine, Iran University of Medical Sciences","place":["Tehran, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Rajaeinejad","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical Branch of Tehran, Islamic Azad University","place":["Tehran, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Jalili","sequence":"additional","affiliation":[{"name":"Department of Nursing, School of Nursing and Midwifery, Qazvin University of Medical Sciences","place":["Qazvin, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokuh","family":"Aghamirzaei","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tehran University of Medical Sciences","place":["Tehran, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Shahabinejad","sequence":"additional","affiliation":[{"name":"Student Research Committee, Rafsanjan University of Medical Sciences","place":["Rafsanjan, Iran"]},{"name":"USERN Office, Rafsanjan University of Medical Sciences","place":["Rafsanjan, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme Sadat","family":"Kouchakzade","sequence":"additional","affiliation":[{"name":"Student Research Committee, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences","place":["Kerman, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Abbaspour","sequence":"additional","affiliation":[{"name":"Department of International Education, I.M. Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Lalegani","sequence":"additional","affiliation":[{"name":"School of Medicine, Isfahan University of Medical Sciences","place":["Isfahan, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Pirsadeghi","sequence":"additional","affiliation":[{"name":"Student Research Committee, Ahvaz Jundishapur University of Medical Sciences","place":["Ahvaz, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taral R.","family":"Lunavat","sequence":"additional","affiliation":[{"name":"Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo","place":["Oslo, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41467-022-28372-y","article-title":"Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target.","volume":"13","author":"Abdelfattah","year":"2022","journal-title":"Nat. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bcmd.2005.07.001","article-title":"Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis.","volume":"35","author":"Abusamra","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.3390\/ijms25063415","article-title":"Hsp70 and calcitonin receptor protein in extracellular vesicles from glioblastoma multiforme: Biomarkers with putative roles in carcinogenesis and potential for differentiating tumor types.","volume":"25","author":"Alberti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1519449","DOI":"10.3389\/freae.2025.1519449","article-title":"Epigenetic mechanisms of plasticity and resistance in glioblastoma: Therapeutic targets and implications.","volume":"3","author":"Amirmahani","year":"2025","journal-title":"Front. Epigenet. Epigenom."},{"key":"B5","doi-asserted-by":"publisher","first-page":"vdaa056","DOI":"10.1093\/noajnl\/vdaa056","article-title":"Molecular profiles and immunomodulatory activities of glioblastoma-derived exosomes.","volume":"2","author":"Azambuja","year":"2020","journal-title":"Neurooncol. Adv."},{"key":"B6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12964-024-01906-1","article-title":"Exosome-based immunotherapy as an innovative therapeutic approach in melanoma.","volume":"22","author":"Babaei","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/sctm.20-0161","article-title":"Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies.","volume":"9","author":"Bajetto","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"B8","first-page":"4021","article-title":"Targeting the multidrug and toxin extrusion 1 gene (SLC47A1) sensitizes glioma stem cells to temozolomide.","volume":"13","author":"Batara","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/21541248.2016.1264352","article-title":"New insights into the function of Rab GTPases in the context of exosomal secretion.","volume":"9","author":"Blanc","year":"2018","journal-title":"Small GTPases"},{"key":"B10","doi-asserted-by":"publisher","first-page":"112760","DOI":"10.1016\/j.biopha.2022.112760","article-title":"Angioregulatory role of miRNAs and exosomal miRNAs in glioblastoma pathogenesis.","volume":"148","author":"Bouzari","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"102279","DOI":"10.1016\/j.ceb.2023.102279","article-title":"Drivers of heterogeneity in the glioblastoma immune microenvironment.","volume":"85","author":"Brosque","year":"2023","journal-title":"Curr. Opin. Cell Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.4049\/jimmunol.0802845","article-title":"NK cells recognize and kill human glioblastoma cells with stem cell-like properties.","volume":"182","author":"Castriconi","year":"2009","journal-title":"J. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.semcancer.2024.04.003","article-title":"Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools.","volume":"101","author":"Cela","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/s41588-021-00927-7","article-title":"Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states.","volume":"53","author":"Chaligne","year":"2021","journal-title":"Nat. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00280-021-04392-1","article-title":"Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.","volume":"89","author":"Chen","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-99-8365-0_1","article-title":"Classification and nomenclature of extracellular vesicles","volume-title":"Extracellular Vesicles: From Bench to Bedside","author":"Chen","year":"2024"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1074\/mcp.RA118.000644","article-title":"The impact of oncogenic EGFRvIII on the proteome of extracellular vesicles released from glioblastoma cells.","volume":"17","author":"Choi","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12964-019-0494-4","article-title":"Extracellular vesicles originating from glioblastoma cells increase metalloproteinase release by astrocytes: The role of CD147 (EMMPRIN) and ionizing radiation.","volume":"18","author":"Colangelo","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1611549","DOI":"10.3389\/pore.2024.1611549","article-title":"Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment.","volume":"30","author":"Dai","year":"2024","journal-title":"Pathol. Oncol. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.20517\/cdr.2019.74","article-title":"The role of exosomal long non-coding RNAs in cancer drug resistance.","volume":"2","author":"De Los Santos","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/ijc.29521","article-title":"Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.","volume":"137","author":"de Vrij","year":"2015","journal-title":"Int. J. Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/neuonc\/noab229","article-title":"Extracellular vesicles: The key for precision medicine in glioblastoma.","volume":"24","author":"Del Bene","year":"2022","journal-title":"Neuro Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13046-021-01942-6","article-title":"Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.","volume":"40","author":"Ding","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.2147\/OTT.S173244","article-title":"H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-\u03baB signaling.","volume":"11","author":"Duan","year":"2018","journal-title":"Onco Targets Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.3390\/ijms22126385","article-title":"Molecular mechanisms of drug resistance in glioblastoma.","volume":"22","author":"Dymova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-019-03545-4","article-title":"Exosomes: Cell-created drug delivery systems.","volume":"459","author":"Familtseva","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"155674","DOI":"10.1016\/j.prp.2024.155674","article-title":"A complete sojourn on exosomes: Potential diagnostic and therapeutic agents.","volume":"264","author":"Garg","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"B28","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41419-022-05056-5","article-title":"Exosomal circWDR62 promotes temozolomide resistance and malignant progression through regulation of the miR-370-3p\/MGMT axis in glioma.","volume":"13","author":"Geng","year":"2022","journal-title":"Cell Death Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1101\/gad.324301.119","article-title":"Glioblastoma stem cells: Lessons from the tumor hierarchy in a lethal cancer.","volume":"33","author":"Gimple","year":"2019","journal-title":"Genes Dev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.stemcr.2017.04.024","article-title":"MicroRNA signatures and molecular subtypes of glioblastoma: The role of extracellular transfer.","volume":"8","author":"Godlewski","year":"2017","journal-title":"Stem Cell Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1096\/fj.08-122184","article-title":"Proteomic and immunologic analyses of brain tumor exosomes.","volume":"23","author":"Graner","year":"2009","journal-title":"FASEB J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in cancer immune response.","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41580-024-00768-2","article-title":"Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics.","volume":"26","author":"Gulati","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1038\/s41388-018-0261-9","article-title":"Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a\/Rora and miR-21\/Pten pathways.","volume":"37","author":"Guo","year":"2018","journal-title":"Oncogene"},{"key":"B35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: From biogenesis to uptake and intracellular signalling.","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"B36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10014-019-00335-0","article-title":"The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.","volume":"36","author":"Hallal","year":"2019","journal-title":"Brain Tumor Pathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/cbr.2019.3492","article-title":"Exosomal circ-HIPK3 facilitates tumor progression and temozolomide resistance by regulating miR-421\/ ZIC5 axis in glioma.","volume":"36","author":"Han","year":"2021","journal-title":"Cancer Biother. Radiopharm."},{"key":"B38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biocel.2014.10.005","article-title":"Glioma cell-derived placental growth factor induces regulatory B cells.","volume":"57","author":"Han","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"32570","DOI":"10.3402\/jev.v5.32570","article-title":"High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.","volume":"5","author":"Haraszti","year":"2016","journal-title":"J. Extracell. Vesicles"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41419-021-04430-z","article-title":"Current landscape of tumor-derived exosomal ncRNAs in glioma progression, detection, and drug resistance.","volume":"12","author":"He","year":"2021","journal-title":"Cell Death Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13073-024-01309-4","article-title":"Deciphering cancer cell state plasticity with single-cell genomics and artificial intelligence.","volume":"16","author":"Holton","year":"2024","journal-title":"Genome Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/neuonc\/noad159","article-title":"EPIC-1042 as a potent PTRF\/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma.","volume":"26","author":"Hong","year":"2024","journal-title":"Neuro Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"21722","DOI":"10.1021\/acsami.4c04289","article-title":"Overcoming the blood-brain tumor barrier with docetaxel-loaded mesoporous silica nanoparticles for treatment of temozolomide-resistant glioblastoma.","volume":"16","author":"Hsu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12038-020-00072-z","article-title":"Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging miR-1294.","volume":"45","author":"Hua","year":"2020","journal-title":"J. Biosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"109233","DOI":"10.1016\/j.biopha.2019.109233","article-title":"Circular RNAs in drug resistant tumors.","volume":"118","author":"Hua","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41698-024-00600-2","article-title":"Extracellular vesicles in glioblastoma: A challenge and an opportunity.","volume":"8","author":"Indira Chandran","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jneuroim.2015.11.025","article-title":"The limited capacity of malignant glioma-derived exosomes to suppress peripheral immune effectors.","volume":"290","author":"Iorgulescu","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e18138","DOI":"10.1111\/jcmm.18138","article-title":"Exosome inhibition improves response to first-line therapy in small cell lung cancer.","volume":"28","author":"Irep","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1080\/14737159.2020.1844006","article-title":"Diagnostic accuracy of cerebrospinal fluid and serum-isolated extracellular vesicles for glioblastoma: A systematic review and meta-analysis.","volume":"20","author":"Jafari","year":"2020","journal-title":"Expert Rev. Mol. Diagn."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.2147\/OTT.S96278","article-title":"Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy.","volume":"9","author":"Jiang","year":"2016","journal-title":"Onco Targets Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"995498","DOI":"10.3389\/fonc.2022.995498","article-title":"Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities.","volume":"12","author":"Johnson","year":"2022","journal-title":"Front. Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"vdac017","DOI":"10.1093\/noajnl\/vdac017","article-title":"Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-\u03b3 through PD-L1 and IDO1.","volume":"4","author":"Jung","year":"2022","journal-title":"Neurooncol. Adv."},{"key":"B53","doi-asserted-by":"publisher","first-page":"8701","DOI":"10.1007\/s11033-022-07714-5","article-title":"Temozolomide increases heat shock proteins in extracellular vesicles released from glioblastoma cells.","volume":"49","author":"K\u0131yga","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nature06309","article-title":"Adaptive immunity maintains occult cancer in an equilibrium state.","volume":"450","author":"Koebel","year":"2007","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/biomedicines10010151","article-title":"Dynamic intercell communication between glioblastoma and microenvironment through extracellular vesicles.","volume":"10","author":"Krape\u017e","year":"2022","journal-title":"Biomedicines"},{"key":"B56","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.1073\/pnas.1220998110","article-title":"Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.","volume":"110","author":"Kucharzewska","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases.","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/pr9020273","article-title":"Extracellular vesicle transportation and uptake by recipient cells: A critical process to regulate human diseases.","volume":"9","author":"Kwok","year":"2021","journal-title":"Processes"},{"key":"B59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5603\/fhc.109684","article-title":"Exosomal Lnc-DLK1-35 reprograms microglia into a pro-tumorigenic phenotype via a non-canonical cytokine signature to promote glioblastoma progression and chemoresistance.","volume":"64","author":"Li","year":"2026","journal-title":"Folia Histochem. Cytobiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1089\/cbr.2021.0299","article-title":"Exosome-mediated transfer of circ- GLIS3 enhances temozolomide resistance in glioma cells through the miR-548m\/MED31 axis.","volume":"38","author":"Li","year":"2023","journal-title":"Cancer Biother. Radiopharm."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1159\/000478917","article-title":"Long non-coding RNA MALAT1 decreases the sensitivity of resistant glioblastoma cell lines to temozolomide.","volume":"42","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7555\/JBR.36.20220156","article-title":"Glioblastoma multiforme: Diagnosis, treatment, and invasion.","volume":"37","author":"Li","year":"2022","journal-title":"J. Biomed. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3389\/fimmu.2017.01748","article-title":"Novel therapy for glioblastoma multiforme by restoring LRRC4 in tumor cells: LRRC4 inhibits tumor-infitrating regulatory T cells by cytokine and programmed cell death 1-containing exosomes.","volume":"8","author":"Li","year":"2017","journal-title":"Front. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/cns.12089","article-title":"MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma.","volume":"19","author":"Li","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s12276-022-00856-3","article-title":"Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer.","volume":"54","author":"Li","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1158\/2326-6066.CIR-21-0258","article-title":"Glioblastoma cell-derived lncRNA-containing exosomes induce microglia to produce complement C5, promoting chemotherapy resistance.","volume":"9","author":"Li","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s13046-019-1371-0","article-title":"Modulating lncRNA SNHG15\/CDK6\/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1016\/j.wneu.2019.08.117","article-title":"Galectin-9: A predictive biomarker negatively regulating immune response in glioma patients.","volume":"132","author":"Liang","year":"2019","journal-title":"World Neurosurg."},{"key":"B69","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/cells13040336","article-title":"Challenges and promise for glioblastoma treatment through extracellular vesicle inquiry.","volume":"13","author":"Liguori","year":"2024","journal-title":"Cells"},{"key":"B70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12951-023-01801-w","article-title":"Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling.","volume":"21","author":"Liu","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"309","DOI":"10.7314\/apjcp.2013.14.1.309","article-title":"Exosomes from murine-derived GL26 cells promote glioblastoma tumor growth by reducing number and function of CD8+T cells.","volume":"14","author":"Liu","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1021\/acsnano.3c11427","article-title":"Proteomic, metabolomic, and fatty acid profiling of small extracellular vesicles from glioblastoma stem-like cells and their role in tumor heterogeneity.","volume":"18","author":"Lokumcu","year":"2024","journal-title":"ACS Nano"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1291177","DOI":"10.3389\/fonc.2023.1291177","article-title":"Roles of extracellular vesicles in glioblastoma: Foes, friends and informers.","volume":"13","author":"Lunavat","year":"2023","journal-title":"Front. Oncol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.3390\/ijms23052770","article-title":"Extracellular vesicles secreted by glioma stem cells are involved in radiation resistance and glioma progression.","volume":"23","author":"Ma","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.tibtech.2024.08.007","article-title":"Engineering therapeutical extracellular vesicles for clinical translation.","volume":"43","author":"Ma","year":"2025","journal-title":"Trends Biotechnol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-019-0965-7","article-title":"Extracellular vesicles-mediated intercellular communication: Roles in the tumor microenvironment and anti-cancer drug resistance.","volume":"18","author":"Maacha","year":"2019","journal-title":"Mol. Cancer"},{"key":"B77","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1007\/s11010-021-04221-2","article-title":"Exosomal noncoding RNAs: Key players in glioblastoma drug resistance.","volume":"476","author":"Movahedpour","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1060000","DOI":"10.3389\/fcell.2023.1060000","article-title":"Effects of glioblastoma-derived extracellular vesicles on the functions of immune cells.","volume":"11","author":"Musatova","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e0213069","DOI":"10.1371\/journal.pone.0213069","article-title":"The P4-ATPase ATP9A is a novel determinant of exosome release.","volume":"14","author":"Naik","year":"2019","journal-title":"PLoS One"},{"key":"B80","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.biomaterials.2018.06.013","article-title":"Perivascular signals alter global gene expression profile of glioblastoma and response to temozolomide in a gelatin hydrogel.","volume":"198","author":"Ngo","year":"2019","journal-title":"Biomaterials"},{"key":"B81","doi-asserted-by":"publisher","first-page":"8414","DOI":"10.1021\/acs.nanolett.5c01897","article-title":"Simultaneous targeting of tumor cells and tumor-associated macrophages to reprogram glioblastoma using trypsinized extracellular vesicles carrying tumor suppressive MicroRNA.","volume":"25","author":"Nguyen","year":"2025","journal-title":"Nano Lett."},{"key":"B82","doi-asserted-by":"publisher","first-page":"20160477","DOI":"10.1098\/rstb.2016.0477","article-title":"Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype.","volume":"373","author":"Oushy","year":"2018","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13041-024-01113-6","article-title":"MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma.","volume":"17","author":"Palizkaran Yazdi","year":"2024","journal-title":"Mol. Brain"},{"key":"B84","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13206-025-00232-z","article-title":"Critical challenges and future direction in extracellular vesicle research and commercialization.","volume":"19","author":"Park","year":"2025","journal-title":"BioChip J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cytogfr.2023.05.001","article-title":"The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance.","volume":"73","author":"Pol\u00f3nia","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/ijms27041676","article-title":"Therapeutic potential of extracellular vesicles: From biogenesis, isolation and molecular characterization to addressing translational gaps and regulatory barriers.","volume":"27","author":"Primorac","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1126\/science.aaf2666","article-title":"An anatomic transcriptional atlas of human glioblastoma.","volume":"360","author":"Puchalski","year":"2018","journal-title":"Science"},{"key":"B88","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41388-019-0996-y","article-title":"Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-\u03baB pathways.","volume":"39","author":"Qian","year":"2020","journal-title":"Oncogene"},{"key":"B89","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.mam.2017.12.003","article-title":"Role of extracellular vesicles in glioma progression.","volume":"60","author":"Quezada","year":"2018","journal-title":"Mol. Aspects Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"36405","DOI":"10.31083\/FBL36405","article-title":"Extracellular vesicles: Recent advances and perspectives.","volume":"30","author":"Ragni","year":"2025","journal-title":"Front. Biosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"eaar2766","DOI":"10.1126\/sciadv.aar2766","article-title":"Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.","volume":"4","author":"Ricklefs","year":"2018","journal-title":"Sci. Adv."},{"key":"B92","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3389\/fonc.2018.00448","article-title":"Epigenetic targeting of glioblastoma.","volume":"8","author":"Romani","year":"2018","journal-title":"Front. Oncol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2217\/nnm-2019-0431","article-title":"Characterization and antiproliferative activity of glioma-derived extracellular vesicles.","volume":"15","author":"Scholl","year":"2020","journal-title":"Nanomedicine"},{"key":"B94","doi-asserted-by":"publisher","first-page":"108807","DOI":"10.1016\/j.isci.2024.108807","article-title":"Glioblastoma extracellular vesicles modulate immune PD-L1 expression in accessory macrophages upon radiotherapy.","volume":"27","author":"Schweiger","year":"2024","journal-title":"iScience"},{"key":"B95","doi-asserted-by":"publisher","first-page":"7974","DOI":"10.3390\/ijms25147974","article-title":"Circulating liquid biopsy biomarkers in glioblastoma: Advances and challenges.","volume":"25","author":"Seyhan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.62347\/JWMX3035","article-title":"Decoding the secrets of small extracellular vesicle communications: Exploring the inhibition of vesicle-associated pathways and interception strategies for cancer treatment.","volume":"14","author":"Shams","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.1038\/ncomms7999","article-title":"Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma.","volume":"6","author":"Shao","year":"2015","journal-title":"Nat. Commun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"vdad009","DOI":"10.1093\/noajnl\/vdad009","article-title":"Tumor microenvironment in glioblastoma: Current and emerging concepts.","volume":"5","author":"Sharma","year":"2023","journal-title":"Neurooncol. Adv."},{"key":"B99","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/biology12010110","article-title":"Extracellular vesicles: New classification and tumor immunosuppression.","volume":"12","author":"Sheta","year":"2023","journal-title":"Biology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e924023","DOI":"10.12659\/MSM.924023","article-title":"Role of exosomes in the progression, diagnosis, and treatment of gliomas.","volume":"26","author":"Shi","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"B101","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/biomedicines11030779","article-title":"Effect of polyunsaturated fatty acids on temozolomide drug-sensitive and drug-resistant glioblastoma cells.","volume":"11","author":"Silva","year":"2023","journal-title":"Biomedicines"},{"key":"B102","doi-asserted-by":"publisher","first-page":"10162","DOI":"10.3390\/ijms241210162","article-title":"Exosomes as novel diagnostic biomarkers and therapeutic tools in gliomas.","volume":"24","author":"Skouras","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1073\/pnas.1219747110","article-title":"Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.","volume":"110","author":"Sottoriva","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B104","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12885-023-11271-w","article-title":"Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: Effects on cell death, self-renewal, and invasion.","volume":"23","author":"Sousa","year":"2023","journal-title":"BMC Cancer"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1490144","DOI":"10.1080\/20013078.2018.1490144","article-title":"Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities.","volume":"7","author":"Spinelli","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"B106","doi-asserted-by":"publisher","first-page":"36137","DOI":"10.18632\/oncotarget.16661","article-title":"Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21\/VEGF signal.","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"B107","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10571-019-00771-8","article-title":"Glioblastoma stem cell-derived exosomes enhance stemness and tumorigenicity of glioma cells by transferring Notch1 protein.","volume":"40","author":"Sun","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/ijms22031463","article-title":"CD44 and Tumor-Derived Extracellular Vesicles (TEVs). Possible gateway to cancer metastasis.","volume":"22","author":"Szatanek","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3390\/nano13101611","article-title":"The roles of extracellular vesicles in the progression of renal cell carcinoma and their potential for future clinical application.","volume":"13","author":"Takeda","year":"2023","journal-title":"Nanomaterials"},{"key":"B110","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.trecan.2016.08.001","article-title":"Targeting the microenvironment in advanced colorectal cancer.","volume":"2","author":"Tauriello","year":"2016","journal-title":"Trends Cancer"},{"key":"B111","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bios.2017.03.036","article-title":"Direct detection of two different tumor-derived extracellular vesicles by SAM-AuNIs LSPR biosensor.","volume":"94","author":"Thakur","year":"2017","journal-title":"Biosens. Bioelectron."},{"key":"B112","doi-asserted-by":"publisher","first-page":"eaaz6119","DOI":"10.1126\/sciadv.aaz6119","article-title":"Label-free sensing of exosomal MCT1 and CD147 for tracking metabolic reprogramming and malignant progression in glioma.","volume":"6","author":"Thakur","year":"2020","journal-title":"Sci. Adv."},{"key":"B113","doi-asserted-by":"publisher","first-page":"113476","DOI":"10.1016\/j.bios.2021.113476","article-title":"In vivo liquid biopsy for glioblastoma malignancy by the AFM and LSPR based sensing of exosomal CD44 and CD133 in a mouse model.","volume":"191","author":"Thakur","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"B114","doi-asserted-by":"publisher","first-page":"188616","DOI":"10.1016\/j.bbcan.2021.188616","article-title":"Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.","volume":"1876","author":"Tomar","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1359479","DOI":"10.1080\/20013078.2017.1359479","article-title":"Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles.","volume":"6","author":"Treps","year":"2017","journal-title":"J. Extracell. Vesicles"},{"key":"B116","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3892\/ijo.2021.5244","article-title":"Exosomal transfer of miR-25-3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7.","volume":"59","author":"Wang","year":"2021","journal-title":"Int. J. Oncol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.18632\/oncotarget.2116","article-title":"MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma.","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"B118","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41419-020-03042-3","article-title":"Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity.","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41419-021-04359-3","article-title":"CD73-positive extracellular vesicles promote glioblastoma immunosuppression by inhibiting T-cell clonal expansion.","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment.","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"B121","doi-asserted-by":"publisher","first-page":"112505","DOI":"10.1016\/j.colsurfb.2022.112505","article-title":"Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment.","volume":"215","author":"Wang","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.7150\/ijbs.57168","article-title":"Identification of low-dose radiation-induced exosomal circ-METRN and miR-4709-3p\/GRB14\/PDGFR\u03b1 pathway as a key regulatory mechanism in Glioblastoma progression and radioresistance: Functional validation and clinical theranostic significance.","volume":"17","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41419-022-04699-8","article-title":"Serum-derived extracellular vesicles facilitate temozolomide resistance in glioblastoma through a HOTAIR-dependent mechanism.","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/10408363.2019.1700208","article-title":"Extracellular vesicles and their role in glioblastoma.","volume":"57","author":"Whitehead","year":"2019","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"B125","first-page":"2835","article-title":"MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells.","volume":"32","author":"Wong","year":"2012","journal-title":"Anticancer Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.2147\/DDDT.S382690","article-title":"Exosomes derived from hypoxic glioma cells reduce the sensitivity of glioma cells to temozolomide through carrying miR-106a-5p.","volume":"16","author":"Wu","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"B127","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11060-024-04934-6","article-title":"Glioblastoma- derived exosomes (GBM-Exo) regulate microglial M2 polarization via the RAC1\/AKT\/NRF2 pathway.","volume":"172","author":"Wu","year":"2025","journal-title":"J. Neurooncol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"e12146","DOI":"10.1002\/jev2.12146","article-title":"Hypoxia-stimulated ATM activation regulates autophagy-associated exosome release from cancer-associated fibroblasts to promote cancer cell invasion.","volume":"10","author":"Xi","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1388700","DOI":"10.3389\/fonc.2024.1388700","article-title":"The tumor-associated fibrotic reactions in microenvironment aggravate glioma chemoresistance.","volume":"14","author":"Xu","year":"2024","journal-title":"Front. Oncol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41419-024-06695-6","article-title":"Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide.","volume":"15","author":"Xu","year":"2024","journal-title":"Cell Death Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fcell.2019.00217","article-title":"Novel function of lncRNA ADAMTS9-AS2 in promoting temozolomide resistance in glioblastoma via upregulating the FUS\/MDM2 ubiquitination axis.","volume":"7","author":"Yan","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.7150\/thno.71763","article-title":"PTRF\/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma.","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"key":"B133","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11060-016-2308-5","article-title":"Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma.","volume":"131","author":"Yang","year":"2017","journal-title":"J. Neurooncol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12935-024-03389-z","article-title":"The role and application of small extracellular vesicles in glioma.","volume":"24","author":"Yang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.7150\/ijms.71912","article-title":"Exosomes derived from glioma cells under hypoxia promote angiogenesis through up-regulated exosomal connexin 43.","volume":"19","author":"Yang","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20517\/cdr.2020.61","article-title":"The role of extracellular vesicles in acquisition of resistance to therapy in glioblastomas.","volume":"4","author":"Yekula","year":"2021","journal-title":"Cancer Drug Resist."},{"key":"B137","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.3389\/fimmu.2019.03137","article-title":"Extracellular vesicles in glioblastoma tumor microenvironment.","volume":"10","author":"Yekula","year":"2020","journal-title":"Front. Immunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.7150\/thno.47057","article-title":"Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.","volume":"11","author":"Yin","year":"2021","journal-title":"Theranostics"},{"key":"B139","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ebiom.2019.03.016","article-title":"Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.","volume":"42","author":"Yin","year":"2019","journal-title":"EBioMedicine"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2019.3499","article-title":"Exosome-mediated transfer of long noncoding RNA HOTAIR regulates temozolomide resistance by miR-519a-3p\/RRM1 axis in glioblastoma.","author":"Yuan","year":"2020","journal-title":"Cancer Biother. Radiopharm."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.ymthe.2019.07.011","article-title":"Hypoxic glioma cell-secreted exosomal miR-301a activates Wnt\/\u03b2-catenin signaling and promotes radiation resistance by targeting TCEAL7.","volume":"27","author":"Yue","year":"2019","journal-title":"Mol. Ther."},{"key":"B142","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13046-025-03336-4","article-title":"Innovative dual-gene delivery platform using miR-124 and PD-1 via umbilical cord mesenchymal stem cells and exosome for glioblastoma therapy.","volume":"44","author":"Yueh","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.3390\/cancers15153804","article-title":"The current landscape of glioblastoma biomarkers in body fluids.","volume":"15","author":"Zanganeh","year":"2023","journal-title":"Cancers"},{"key":"B144","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2018.08.004","article-title":"Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.","volume":"436","author":"Zeng","year":"2018","journal-title":"Cancer Lett."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e2427073122","DOI":"10.1073\/pnas.2427073122","article-title":"A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity.","volume":"122","author":"Zhang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B146","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biopha.2018.10.063","article-title":"Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions.","volume":"109","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/pharmaceutics16111394","article-title":"Minimal Information for Studies of Extracellular Vesicles (MISEV): Ten-year evolution (2014-2023).","volume":"16","author":"Zhang","year":"","journal-title":"Pharmaceutics"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1473030","DOI":"10.3389\/fimmu.2024.1473030","article-title":"The role of exosomes in liver cancer: Comprehensive insights from biological function to therapeutic applications.","volume":"15","author":"Zhang","year":"","journal-title":"Front. Immunol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13046-019-1139-6","article-title":"Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s10637-019-00884-3","article-title":"Microarray expression profiles and bioinformatics analysis of mRNAs, lncRNAs, and circRNAs in the secondary temozolomide-resistant glioblastoma.","volume":"38","author":"Zhao","year":"2020","journal-title":"Invest. New Drugs"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.3892\/or.2019.6972","article-title":"Expression profiles and potential functions of circular RNAs in extracellular vesicles isolated from radioresistant glioma cells.","volume":"41","author":"Zhao","year":"2019","journal-title":"Oncol. Rep."},{"key":"B152","doi-asserted-by":"publisher","first-page":"103365","DOI":"10.1016\/j.ebiom.2021.103365","article-title":"Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy.","volume":"67","author":"Zhou","year":"2021","journal-title":"EBioMedicine"},{"key":"B153","doi-asserted-by":"publisher","first-page":"17309","DOI":"10.1021\/acsnano.4c14573","article-title":"Glioblastoma cell derived exosomes as a potent vaccine platform targeting primary brain cancers and brain metastases.","volume":"19","author":"Zou","year":"","journal-title":"ACS Nano"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1671963","DOI":"10.3389\/fbioe.2025.1671963","article-title":"Clinical applications of extracellular vesicles: Recent advances and emerging trends.","volume":"13","author":"Zou","year":"","journal-title":"Front. Bioeng. Biotechnol."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2026.1705115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:32:12Z","timestamp":1781613132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2026.1705115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":154,"alternative-id":["10.3389\/fnmol.2026.1705115"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2026.1705115","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"article-number":"1705115"}}